Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Cancer Research|August 8, 2025
Caloric Restriction Enhances the Efficacy of Anti-Androgen Therapy in Prostate Cancer by Inhibiting Androgen Receptor TranslationRicardo A Cordova, May Elbanna, Christopher Rupert, et al.Neuroimage|March 5, 2024
Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodiesNeha Atulkumar Singh, Austin W Goodrich, Jonathan Graff-Radford, et al.Science Advances|April 8, 2021
Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancerSu H Park, Ka-Wing Fong, Jung Kim, et al.Molecular Cancer Research : MCR|April 27, 2025
Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular VesiclesCandice L Bizzaro, Camila A Bach, Ricardo A Santos, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progressionSilvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli, et al.Biorxiv : the Preprint Server for Biology|August 13, 2025
Reversible therapeutic resistance in <i>EGFR</i> mutant lung cancer caused by <i>RB1</i> loss induced lineage plasticityLetian Zhang, Meenalakshmi Chinnam, Bradley Balk, et al.Journal of the International Neuropsychological Society : JINS|March 25, 2024
Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathologyCarling G Robinson, Austin W Goodrich, Stephen D Weigand, et al.The Journal of Clinical Investigation|July 18, 2024
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancerSheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 1, 2025
An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung TumorigenesisReza Bayat Mokhtari, Divyaleka Sampath, Paige Eversole, et al.Scientific Reports|November 7, 2022
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancerFabio Quaglia, Shiv Ram Krishn, Khalid Sossey-Alaoui, et al.Pageof 12